BIWEEKLY PACLITAXEL (TAXOL) AND CISPLATIN IN BREAST AND OVARIAN-CANCER

被引：0
|
作者：
GELMON, KA
机构：
来源：
SEMINARS IN ONCOLOGY | 1994年 / 21卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 28
页数：5
相关论文
共 50 条
  • [21] INTRAPERITONEAL PACLITAXEL IN THE MANAGEMENT OF OVARIAN-CANCER
    MARKMAN, M
    SEMINARS IN ONCOLOGY, 1995, 22 (05) : 86 - 87
  • [22] Biweekly paclitaxel combined with cisplatin in the treatment of metastatic breast cancer (MBC) previously treated with anthracyclines
    Donat, Dragutin A.
    Pesic, Jasna
    Muzikravic, Ljubomir
    Trifunovic, Jasna
    Zivanovic, Aleksandar
    ANNALS OF ONCOLOGY, 2004, 15 : 40 - 40
  • [23] CARBOPLATIN VERSUS CISPLATIN IN OVARIAN-CANCER
    ALBERTS, DS
    SEMINARS IN ONCOLOGY, 1995, 22 (05) : 88 - 90
  • [24] TAXOL SENSITIZES HUMAN OVARIAN-CANCER CELLS TO RADIATION
    STEREN, A
    SEVIN, BU
    PERRAS, J
    ANGIOLI, R
    NGUYEN, H
    GUERRA, L
    KOECHLI, O
    AVERETTE, HE
    GYNECOLOGIC ONCOLOGY, 1993, 48 (02) : 252 - 258
  • [25] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Armstrong, DK
    Bundy, B
    Wenzel, L
    Huang, HQ
    Baergen, R
    Lele, S
    Copeland, LJ
    Walker, JL
    Burger, RA
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 34 - 43
  • [26] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Hariprasad, Roopa
    Kumar, Lalit
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2006, 27 (03) : 35 - 38
  • [27] PACLITAXEL, CISPLATIN, AND CYCLOPHOSPHAMIDE IN HUMAN OVARIAN-CANCER - MOLECULAR RATIONALE AND EARLY CLINICAL-RESULTS
    REED, E
    KOHN, EC
    SAROSY, G
    DABHOLKAR, M
    DAVIS, P
    JACOB, J
    MAHER, M
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 90 - 96
  • [28] PACLITAXEL PLUS CARBOPLATIN IN THE TREATMENT OF OVARIAN-CANCER
    HUININK, WT
    VEENHOF, C
    HELMERHORST, T
    BIERHORST, F
    DALESIO, O
    WINOGRAD, B
    DEPAUW, L
    PINEDO, HM
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 97 - 100
  • [29] USE OF TAXOL (PACLITAXEL) IN BREAST-CANCER
    HORTOBAGYI, GN
    HOLMES, FA
    THERIAULT, RL
    BUZDAR, AU
    ONCOLOGY, 1994, 51 : 29 - 32
  • [30] The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells
    Ying-Hsi Lin
    Bert Yu-Hung Chen
    Wei-Ting Lai
    Shao-Fu Wu
    Jih-Hwa Guh
    Ann-Lii Cheng
    Lih-Ching Hsu
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, 388 : 19 - 31
12345